IQVIA Holdings (NYSE: IQV) reported Q4 EPS of $1.50, $0.03 better than the analyst estimate of $1.47. Revenue for the quarter came in at $2.69 billion versus the consensus estimate of $2.62 billion.

• Revenue of $2,688 million for the fourth quarter and $10,412 million for the full year
• Adjusted EBITDA of $583 million for the fourth quarter and $2,224 million for the full year
• GAAP Diluted Earnings per Share of $0.34 for the fourth quarter and $1.24 for the full year
• Adjusted Diluted Earnings per Share of $1.50 for the fourth quarter and $5.55 for the full year
• Record quarter of R&D Solutions contracted services Net New Business, resulting in a book-to-bill ratio of 1.7x for the quarter
• Full-year contracted services Net New Business growth of 28.9 percent, contributing to total backlog of over $17.1 billion
• $604 million of share repurchase completed during the fourth quarter; $1.4 billion of share repurchase completed in 2018; authorization increased by $2.0 billion
• Full-year 2019 revenue guidance of $10,900 million to $11,125 million, Adjusted EBITDA of $2,375 million to $2,425 million and Adjusted Diluted Earnings per Share of $6.20 to $6.40

“We closed 2018 with a strong quarter, and delivered results at the high end of, or above our financial targets, capping a year of outstanding performance,” said Ari Bousbib, chairman and CEO of IQVIA. “Our clinical development team had another record quarter of contracted net new business, and our technology team continued to add impressive new client wins for our OCE SaaS platform. As we enter the third year of our merger integration, we are pleased to see the beginning of top line acceleration in both our R&DS and TAS businesses. We are also encouraged that our CSMS business is showing positive signs of stabilization as we head into 2019. Across all our businesses, the IQVIA team is building momentum to further accelerate growth beyond 2019.”

GUIDANCE:

IQVIA Holdings sees FY2019 EPS of $6.20-$6.40, versus the consensus of $6.24. IQVIA Holdings sees FY2019 revenue of $10.9-11.125 billion, versus the consensus of $10.87 billion.

For earnings history and earnings-related data on IQVIA Holdings (IQV) click here.